尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Goldenberg Gary. Officer active across 1 company, notably Verrica Pharmaceuticals Inc.. Cumulatively, 8 reports have been published. Breakdown: 1 buy · 3 sells. Total volume traded: €208k. Activity tracked since 5 July 2022. The latest transaction was filed on 24 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Goldenberg Gary is a declarant linked to Verrica Pharmaceuticals Inc., where he serves as Chief Medical Officer. He has 8 filings in total, and across the sampled recent filings from 2022-07-05 to 2025-02-06, the reported volumes are EUR 48743 in buys and EUR 158910 in sells, with the dominant transaction nature listed as Attribution.